Dr. Seder did his postdoctoral training in the Laboratory of Immunology at the National Institute of Allergy and Infectious Diseases (NIAID) under Dr. William Paul from 1989-1993 and in 1994 became Chief of the Clinical Immunology Section in the Laboratory of Clinical Investigation, NIAID. Dr. Seder was then appointed as Chief of the Cellular Immunology Section in the Vaccine Research Center (VRC) in 2000. Since joining the VRC, Dr. Seder has focused on understanding the innate and adaptive mechanisms by which various vaccines, adjuvants and delivery approaches mediate protective immunity in pre-clinical models of HIV, Malaria and Tuberculosis infection and tumors. A major emphasis of Dr. Seder’s work is the translation of these scientific discoveries into clinical vaccine trials against malaria, TB and cancer. In addition to these vaccine efforts, Dr. Seder will assess whether passive immunization with a recently discovered monoclonal antibody can prevent malaria infection.